Thesis Presented by Selma HOUCHI Submitted for the Fulfillment of the Requirements for the Degree of Doctorate of Sciences in Biology

Total Page:16

File Type:pdf, Size:1020Kb

Thesis Presented by Selma HOUCHI Submitted for the Fulfillment of the Requirements for the Degree of Doctorate of Sciences in Biology الجمهورية الجزائرية الديمقراطية الشعبية وزارة التعليم العالي و البحث العلمي جامعة فرحات عباس، سطيف University of Ferhat Abbas Setif 1 1 كلية علوم الطبيعة و الحياة Faculty of Life and Nature Sciences DEPARTMENT OF BIOCHEMISTRY N°………………………………………….…………..…….……/SNV/2019 Thesis Presented by Selma HOUCHI Submitted for the fulfillment of the requirements for the degree of Doctorate of Sciences In Biology OPTION: Biochemistry Theme Characterization of ß-lactamase genes in clinical isolates and determination of the inhibitory effects of Algerian seaweeds extracts on recombinant ß-lactamases GES-22 and OXA-1 Discussed on 22/ 07/ 2019 Board of Examiners Chairman Abdelhalim KHENCHOUCHE Associated professor (A). UFA Setif-1 Supervisor Rachid MAHDADI Pr. University Ferhat Abbas Setif-1 Examiner Karim HOUALI Pr.Univ. Mouloud Mammeri Tizi Ouzou Examiner El-Hafidh NABTI Pr. Univ. Abderrahmane Mira Bejaia Examiner Kamel AISSET Pr. Univ. Hadj Lakhdar Batna-1 Examiner Widad SOBHI Associated professor (A). UFA-Setif-1 Invited member Cemal SANDALLI Pr. Recep Tayyip Erdogan University, Turkey Laboratory of Applied Biochemistry In the name of Allah, the Beneficent, the Merciful Dedication I am dedicating this thesis, First and foremost, to my loving parents my father, Ahmed, May Allah grant him Jannah Firdaws. and My mother MAIZA Hafsa for their love, endless support and encouragement To the people who helped me a lot and for their support moral and their sacrifices along my PhD; My dear brothers Abdelkarim, Faycel and Mounir To my dear cousin Khaoula Acknowledgements First and foremost, I would like to thank ALLAH Almighty for giving me the strength, ability and opportunity to undertake this modest research study. There are many people who have helped me during this study. There is not enough space, nor words, to acknowledge everyone to the extent they deserve. I hope people understand the brevity of this part. First of all, I would like to thank my doctorate advisor and research guide at Ferhat Abbas SETIF-1 University, (ALGERIA) Professor Rachid MAHDADI. Under his guidance, I was given the freedom to pursue my research in my own way and I greatly appreciated that freedom. It was a great pleasure to work with him. Thanks for supporting and encouraging me through these years. Additionally, I would like to thank the jury members for agreeing to judge this work and to be the examiners of this thesis: Dr. Abdelhalim KHENCHOUCHE, for agreeing to judge this work and to do me the honor of chairing this thesis jury. Pr. Karim HOUALI, Pr. El-Hafidh NABTI and Pr. Kamel AISSET, Dr. Widad SOBHI to have accepted to judge this work. I am deeply grateful to all members of the jury for agreeing to read the manuscript and to participate in the defense of this thesis. The realization of this work was only possible due to the several people's collaboration, to which desire to express my gratefulness: To Pr. Cemal sandalli at Recep tayyib Erdogan University, (TURKEY) and to all his team at the Microbiology and Molecular Biology Research Laboratory. With deep sense of gratitude, I owe sincere thanks to him for agreeing to participate in the defense of this thesis as invited member. Pr. Guanhua DUGH and Pr. ZHANG Li at Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (CHINA), and all the staff of the Laboratory of Bioactive Substances and Functions of Natural Medicines. Pr. Hassiba TALI-MAAMAR at the Medical bacteriology laboratory in Pasteur institute, Dely Brahim (ALGERIA) and all members of this Laboratory Dr. Wahid REFES. Associated Professor at the National Higher School of Marine Sciences and Coastal Management (ENSSMAL). The Marine and Littoral Ecosystems Laboratory (ECOSYSMarL), (ALGERIA) and to his student my dear colleague BAHRI Nabila. Dr. Moussa MENNAD. Elected representative of the research staff of the National Center for Research and Development of Fisheries and Aquaculture (CNRDPA), Bou Ismail, Tipaza (ALGERIA). I also take a real pleasure to thank Dr. Abdelhakim AOUF at Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences, University of Science and Technology Houari Boumediene, Algiers, (ALGERIA). I would also like to thank all the members of the Laboratory of Applied Biochemistry (Ferhat Abbas SETIF-1 University, ALGERIA). Particularly: Pr.Lekhmici ARRAR and Pr.Noureddine CHAREF. Besides this, I would like to thank Dr. Azeddine TEMAMNA may ALLAH grant him vast paradise; Pr. Abdelouahab BOUZIDI; Pr.Rachid BELHATTAB; Pr. Hammama BOURICHE and Pr. M. Mihoub ZERROUG. ملخص هدفت هذه الدراسة الى تحديد نوع الجينات المشفرة لبناء اﻻنزيمات المسماة بيتاﻻكتماز و كذا شيوعها في عزﻻت بكتيرية سالبة الغرام جمعت من خارج و داخل مستشفيات جزائرية. هدفت أيضا الى التحقق من قدرة مستخلصات ميثانولية لسبعة طحالب نامية على الساحل الجزائري ,Ulva intestinalis, Codium tomentosum, Bryopsis pulmosa] [Sargassum vulgare, Dictyota dichtoma, Halopteris scoparia, Cystoseira compressa على تثبيط نوعين من بيتاﻻكتماز و هما GES-22 و OXA-1. بينت النتائج أن العزﻻت تحوي على اﻷقل جينا واحدا مشفرا لبناء بيتاﻻكتماز ((blaTEM, blaSHV, blaCTX-M1-M2, blaGES, blaPER-2, blaNDM, bla blaOXA-M (23,24,51,58) و ﻻ تحوي أي من الجينات (blaKPC, blaVIM, blaIMP) لكنها بالمقابل تحوي اﻷجزاء المحفوظة بالعليبات الجينية لﻻنتجرونات قسم I و II منفصلة او مجتمعة. تختلف الطحالب السبعة من حيث محتواها من عديدات الفينول الذي تتغير قيمته من 0.65 ± 0.93 و 0.91 ± 3.22 mgGAEs/g DW .تفوق هذه القيمة عند الطحالب الخضراء بمرتين تلك للطحالب البنية. في حين، كان محتوى هذه اﻷخيرة من فيتامين E أعلى من الطحالب الخضراء. بينت الدراسة التحليلية وجود مركبات مشتركة بين المستخلصات المثانولية للطحالب السبعة و هي حمض الفا-لينولينيك (C18: 3 ω3) ، حمض اللينولييك )C18: 2 ω 6( ، حمض اﻷولييك )C18: 1 ω9( ، وحمض اﻷراكيدونيك C20: 4) ω6)(. عﻻوة على هذا، تحوي U.intestinalis و D. dichtoma على بيكالين )C15H10O5( وكركمين )C21H20O6(. يحوي B.pulmosa على بايكالين ودايدزين )C15H10O4(؛ يحوي C. tomentosum على كيرسيتين )C15H10O7( و يحوي C.compressa على )S( نارينجين )C15H12O5(. تراوحت قيم IC50 المحددة على منحى العﻻقة Logit/Log بين 10.31 ± D. dichtoma( µg/mL3..0( إلى .C. compressa( µg/mL 3.10 ± .1.1( و من B.pulmosa( µg/mL 3.90 ± 10.11( إلى C. compressa( µg/mL 1.90 ± 01.09( مع GES-22 و OXA-1 ، على التوالي. أظهر المستخلص المثانولي للطحلب D. dichtoma تأثي ًرا مثب ًطا على GES-22 أكبر من مثبطات β-lactam الكﻻسيكية المسماة كﻻفوﻻنات، سولباكتام و تازوباكتام )IC50= 68.38±0.17µg/mL, 52.68±0.64µg/mL, 29.94±0.01( على التوالي . لم يثبط سولباكتام و كﻻفوﻻنات اﻻنزيم OXA-1، خﻻفا للتازوباكتام (IC50 =243.03± 4.53 μg/mL). أظهر المستخلص الميثانولي لـ B. pulmosa تأثي ًرا مثب ًطا على (OXA-1. (IC50 =13.22 ± 0.9 μg/mL من نتائج نفس اﻻختبارات تصنف كل المستخلصات المثانولية كمثبطات غير تنافسية لـ OXA-1 و GES-22 ، باستثناء المستخلصين لـ B.pulmosa و C. compressa اللذان يثبطان GES-22 بطريقة تنافسية وﻻ تنافسية ،على الترتيب. بينت دراسات المحاكاة إلى أن قوة التثبيط ربما ترجع إلى تكوين روابط هيدروجينية وكارهة للماء بين المركبات التي تم الكشف عنها في المستخلصات المثانولية ومركبات اخرى طبيعية من جهة واﻷحماض اﻷمينية للموقع النشط في كل من Serine وmetallo-β-Lactamases من جهة اخرى. أظهرت جميع المركبات التي تم الكشف عنها في المستخلصات المثانولية للطحالب libdock score وCDOCKER interaction energy أكبر من مثبطات β-lactam الكﻻسيكية مع ß-lactamases 11. يمكن اقتراح hesperidin وdihydromyrecitin و curcumin كمثبطات جيدة على أساس libdock score وCDOCKER interaction energy. الكلمات المفاتيح: بيتاﻻكتاماز، محاكاة، ,Ulva intestinalis, Codium intestinalis, Bryopsis pulmosa Sargassum vulgare, Dictyota dichtoma, Halopteris scoparia, Cystoseira compressa Abstract The main aim of this study was to characterize the type and the prevalence of β-lactamases coding genes in community and nosocomial Algerian Gram negative bacterial isolates, as well as to investigate the inhibitory effects of methanolic extracts of seven seaweeds Of Algerian coast [Ulva intestinalis, Codium tomentosum, Bryopsis pulmosa, Sargassum vulgare, Dictyota dichtoma, Halopteris scoparia, and Cystoseira compressa] against GES-22 and OXA-1 β-lactamases variants. The results showed that isolates harboring at least, one β-lactamase coding gene (blaTEM, blaSHV, blaCTX-M1-M2, blaGES, blaPER-2, blaNDM, bla blaOXA-M (23,24,51,58)); neither blaKPC nor blaVIM, blaIMP gene was detected. The conserved regions of class-I and II integron gene cassettes were determined alone and together in these isolates. The TPC varied among the seven seaweeds species, ranging between 0.93 ± 0.65 and 3.22 ± 0.91 mg GAEs/g DW. TPC in the MEs of green seaweed species were found to be nearly two times greater than that in brown seaweeds. However, vitamin E contents of brown seaweed MEs were higher than those of green seaweeds. Furthermore, qualitative analysis showed the existance of common compounds in the MEs including α-linolenic acid (C18:3 ω3), linoleic acid (C18:2 ω6), oleic acid (C18:1 ω9), and arachidonic acid (C20:4 ω6). Moreover, U. intestinalis and D. dichtoma contain baicalein (C15H10O5) and curcumin (C21H20O6). B. pulmosa contains baicalein and daidzein (C15H10O4); C. tomentosum contains quercetin (C15H10O7) and C. compressa contains (S) naringenin (C15H12O5). Values of IC50 of MEs determined by linear computerized regression analysis after logit/log transformation, are ranged from 13.01 ± 0.46 μg/mL (D. dichtoma) to 41.24 ± 0.23 μg/mL (C. compressa) and from 13.22 ± 0.96 μg/mL (B. pulmosa) to 62.39 ± 1.96 μg/mL (C. compressa) with GES-22 and OXA-1, respectively. ME of D.dichtoma exhibited significant inhibitory effect on GES-22 more than classical β-lactam inhibitors, clavulanate, sulbactam and tazobactam (IC50 = 68.38 ± 0.17 μg/mL, 52.68 ± 0.64 μg/mL, and 29.94 ± 0.01 μg/mL, respectively). OXA-1 was not inhibited by sulbactam and clavulanate and was moderately inhibited by tazobactam (IC50 =243.03± 4.53 μg/mL).
Recommended publications
  • Herbal Medicines in Pregnancy and Lactation : an Evidence-Based
    00 Prelims 1410 10/25/05 2:13 PM Page i Herbal Medicines in Pregnancy and Lactation An Evidence-Based Approach Edward Mills DPh MSc (Oxon) Director, Division of Clinical Epidemiology Canadian College of Naturopathic Medicine North York, Ontario, Canada Jean-Jacques Duguoa MSc (cand.) ND Naturopathic Doctor Toronto Western Hospital Assistant Professor Division of Clinical Epidemiology Canadian College of Naturopathic Medicine North York, Ontario, Canada Dan Perri BScPharm MD MSc Clinical Pharmacology Fellow University of Toronto Toronto, Ontario, Canada Gideon Koren MD FACMT FRCP Director of Motherisk Professor of Medicine, Pediatrics and Pharmacology University of Toronto Toronto, Ontario, Canada With a contribution from Paul Richard Saunders PhD ND DHANP 00 Prelims 1410 10/25/05 2:13 PM Page ii © 2006 Taylor & Francis Medical, an imprint of the Taylor & Francis Group First published in the United Kingdom in 2006 by Taylor & Francis Medical, an imprint of the Taylor & Francis Group, 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN Tel.: ϩ44 (0)20 7017 6000 Fax.: ϩ44 (0)20 7017 6699 E-mail: [email protected] Website: www.tandf.co.uk/medicine All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or trans- mitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP.
    [Show full text]
  • Ginger, the Genus Zingiber {P. N. Ravindran}
    Ginger The Genus Zingiber Ginger The Genus Zingiber Edited by P.N. Ravindran and K. Nirmal Babu Medicinal and Aromatic Plants — Industrial Profiles CRC PRESS Boca Raton London New York Washington, D.C. Library of Congress Cataloging-in-Publication Data Ginger : the genus Zingiber / edited by P.N. Ravindran, K. Nirmal Babu. p. cm.—(Medicinal and aromatic plants—industrial profiles; v. 41) Includes bibliographical references (p. ). ISBN 0-415-32468-8 (alk. Paper) 1. Ginger. I. Ravindran, P.N. II. Nirmal Babu, K. III. Series. SB304.G56 2004 633.8'3—dc22 2004055370 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher. All rights reserved. Authorization to photocopy items for internal or personal use, or the personal or internal use of specific clients, may be granted by CRC Press, provided that $1.50 per page photocopied is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA. The fee code for users of the Transactional Reporting Service is ISBN 0-415-32468-8/05/$0.00+$1.50.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Migraine
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Migraine Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 3 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 3 (+)-PSEUDOEPHEDRINE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 3 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-DICENTRINE 2 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (15:1)-CARDANOL 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 0-METHYLCORYPALLINE 2 Chemical Activity Count 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 7 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 12,118-BINARINGIN 1 12-ACETYLDEHYDROLUCICULINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-OXYINGENOL-ESTER 1 14-ACETOXYCEDROL 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-EPIMETHUENINE 1 16-HYDROXYINGENOL-ESTER 1 2'-HYDROXY-FLAVONE 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-NAPTHOL 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,4-DIMETHOXYTOLUENE 1 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 2 Chemical Activity Count 3-ACETYLACONITINE
    [Show full text]
  • Cover Next Page > Cover Next Page >
    cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_i next page > Page i The Psychopharmacology of Herbal Medicine < previous page page_i next page > cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_ii next page > Page ii This page intentionally left blank. < previous page page_ii next page > < previous page page_iii next page > Page iii The Psychopharmacology of Herbal Medicine Plant Drugs That Alter Mind, Brain, and Behavior Marcello Spinella < previous page page_iii next page > < previous page page_iv next page > Page iv © 2001 Massachusetts Institute of Technology All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher. This book was set in Adobe Sabon in QuarkXPress by Asco Typesetters, Hong Kong and was printed and bound in the United States of America.
    [Show full text]
  • Final Assessment Report on Zingiber Officinale Roscoe, Rhizoma
    27 March 2012 EMA/HMPC/577856/2010 Committee on Herbal Medicinal Products (HMPC) Assessment report on Zingiber officinale Roscoe, rhizoma Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Final Herbal substance(s) (binomial scientific name Zingiber officinale Roscoe, rhizoma. of the plant, including plant part) Herbal preparation(s) Powdered herbal substance. Pharmaceutical form(s) Herbal preparations in solid dosage forms for oral use. Rapporteur Steffen Bager Assessor(s) Dr Med. Lars Ovesen 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ................................................................................................................... 2 1. Introduction ....................................................................................................................... 4 1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof .. 4 1.2. Information about products on the market in the Member States ............................... 5 1.3. Search and assessment methodology ..................................................................... 8 2. Historical data
    [Show full text]
  • Anti-Emetic Mechanisms of Zingiber Officinale Against Cisplatin Induced
    Ullah et al. BMC Complementary and Alternative Medicine (2015) 15:34 DOI 10.1186/s12906-015-0556-0 RESEARCH ARTICLE Open Access Anti-emetic mechanisms of zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates Ihsan Ullah1,2*, Fazal Subhan2, Muhammad Ayaz3, Rehmat Shah2,5, Gowhar Ali2, Ikram Ul Haq4 and Sami Ullah2 Abstract Background: Zingiber officinale (ZO, family Zingiberaceae) has been reported for its antiemetic activity against cancer chemotherapy induced emesis in animal models and in clinics. Current study was designed to investigate ZO for potential usefulness against cisplatin induced vomiting in pigeon and its effects on central and peripheral neurotransmitters involved in the act of vomiting. Methods: Zingiber officinale acetone fraction (ZO-ActFr) was investigated for attenuation of emesis induced by cisplatin in healthy pigeons. Neurotransmitters DA, 5HT and their metabolites DOPAC, HVA and 5HIAA were analyzed using High Performance Liquid Chromatography system coupled with electrochemical detector in area postrema, brain stem and intestine. Antiemetic effect of ZO-ActFr was correlated with central and intestinal neurotransmitters levels in pigeon. Results: Cisplatin (7 mg/kg i.v.) induced emesis without lethality upto the observation period. ZO-ActFr (25, 50 & 100 mg/kg) attenuated cisplatin induced emesis ~ 44.18%, 58.13% (P < 0.05) and 27.9%, respectively; the reference drug, metoclopramide (MCP; 30 mg/kg), produced ~ 48.83% reduction (P < 0.05). ZO-ActFr reduced (P < 0.05 - 0.001) 5-hydroxytryptamine (5HT) concentration in the area postrema, brain stem and intestine at 3rd hour of cisplatin administration, while at the 18th hour ZO treatments attenuated the dopamine upsurge (P < 0.001) caused by cisplatin in the area postrema and 5HT concentration (P < 0.01 - 0.001) in the brain stem and intestine.
    [Show full text]
  • Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: a Guide for Pregnant Women
    Regis University ePublications at Regis University All Regis University Theses Spring 2019 Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women Angela Vu Follow this and additional works at: https://epublications.regis.edu/theses Part of the Alternative and Complementary Medicine Commons, Bioethics and Medical Ethics Commons, and the Hormones, Hormone Substitutes, and Hormone Antagonists Commons Recommended Citation Vu, Angela, "Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women" (2019). All Regis University Theses. 931. https://epublications.regis.edu/theses/931 This Thesis - Open Access is brought to you for free and open access by ePublications at Regis University. It has been accepted for inclusion in All Regis University Theses by an authorized administrator of ePublications at Regis University. For more information, please contact [email protected]. Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women A thesis submitted to Regis College The Honors Program In partial fulfillment of the requirements for Graduation with Honors Angela Vu Honors Thesis May 2019 i Thesis Written By Angela Vu Approved By: Thesis Advisor Thesis Reader or Co-advisor Accepted By: Director, University Honors Program ii iii Table of Contents List of Figures ...............................................................................................................................
    [Show full text]
  • WO 2018/005695 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2018/005695 A l 0 4 January 2018 (04.01.2018) W ! P O PCT (51) International Patent Classification: (72) Inventors: BASTA, Steven; 590 Berkeley Avenue, Menlo A61K 31/4035 (2006.01) A61P 17/04 (2006.01) Park, CA 94025 (US). JOING, Mark; 936 Clara Drive, Pa A61K 45/06 (2006.01) lo Alto, CA 94303 (US). ZHANG, Xiaoming; 1089 Rem- sen Court, Sunnyvale, CA 94087 (US). KWON, Paul; 3349 (21) International Application Number: Deer Hollow Dr, Danville, CA 94506 (US). PCT/US20 17/039829 (74) Agent: SILVERMAN, Lisa, N.; Morrison & Foerster LLP, (22) International Filing Date: 755 Page Mill Road, Palo Alto, CA 94304-1018 (US). 28 June 2017 (28.06.2017) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (30) Priority Data: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 62/356,280 29 June 2016 (29.06.2016) US HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, 62/356,291 29 June 2016 (29.06.2016) US KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 62/356,301 29 June 2016 (29.06.2016) us MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 62/356,294 29 June 2016 (29.06.2016) us OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 62/356,286 29 June 2016 (29.06.2016) us SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, 62/356,271 29 June 2016 (29.06.2016) us TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Chemistry of Spices This Page Intentionally Left Blank Chemistry of Spices
    Chemistry of Spices This page intentionally left blank Chemistry of Spices Edited by Villupanoor A. Parthasarathy Indian Institute of Spices Research Calicut, Kerala, India Bhageerathy Chempakam Indian Institute of Spices Research Calicut, Kerala, India and T. John Zachariah Indian Institute of Spices Research Calicut, Kerala, India CABI is a trading name of CAB International CABI Head Offi ce CABI North American Offi ce Nosworthy Way 875 Massachusetts Avenue Wallingford 7th Floor Oxfordshire OX10 8DE Cambridge, MA 02139 UK USA Tel: +44 (0)1491 832111 Tel: +1 617 395 4056 Fax: +44 (0)1491 833508 Fax: +1 617 354 6875 E-mail: [email protected] E-mail: [email protected] Website: www.cabi.org ©CAB International 2008. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronically, mechanically, by photocopying, recording or otherwise, without the prior permission of the copyright owners. A catalogue record for this book is available from the British Library, London, UK. Library of Congress Cataloging-in-Publication Data Chemistry of spices / [edited by] V.A. Parthasarathy, B. Chempakam, T. John Zachariah. p. cm. Includes bibliographical references and index. ISBN 978-1-84593-405-7 (alk. paper) 1. Spices--Analysis. 2. Spice plants--Composition. I. Parthasarathy, V.A. II. Chempakam, B., Dr. III. Zachariah, T. John. IV. Title. SB305.C44 2008 641.3'383--dc22 2007043551 ISBN-13: 978 1 84593 405 7 Typeset by Spi, Pondicherry, India. Printed and bound in the UK by Biddles Ltd, King’s Lynn. Contents Contributors vii Preface ix 1 Introduction 1 V.A.
    [Show full text]
  • Ginger Extract Defies Changes in Brain Serotonin Levels and Enzymes of Monoamine Metabolism During Withdrawal Following Chronic Ethanol Ingestion
    Global Journal of Biotechnology & Biochemistry 7 (4): 115-124, 2012 ISSN 2078-466X © IDOSI Publications, 2012 DOI: 10.5829/idosi.gjbb.2012.7.4.84214 Ginger Extract Defies Changes In Brain Serotonin Levels and Enzymes of Monoamine Metabolism During Withdrawal Following Chronic Ethanol Ingestion Swaroopa Marella and K. Sathyavelu Reddy Department of Zoology, Division of Exercise Physiology and Molecular Biology, Sri Venkateswara University, Tirupati-517502 Andhra Pradesh, India Abstract: In this study, the ameliorative effects of ginger extract on catecholamine metabolism were investigated in different brain regions of male wistar rats 72h post chronic ethanol (EtOH) ingestion. Main methods:Ethanol (2% w/v) was administered to rats by orogastric intubation. Biochemical investigation was performed for monoamine metabolising enzymes in five groups: (i) Control, (ii) EtOH treated, (iii) EtOH treated along with ginger extract (iv) Ethanol withdrawal (EW) and (v) EtOH withdrawal along with ginger extract groups of rats. Rats in each group were decapitated after six weeks except for the withdrawal groups, which were sacrificed 72h after the last dose of ethanol administration. The brains were removed and cerebral cortex, hippocampus, pons medulla and cerebellum were dissected. The biochemical estimations were done by conventional spectrophotometry. Key findings: Most significant difference in serotonin levels and monoamine metabolizing enzyme activities is observed among normal, ethanol treated and ethanol withdrawal groups (p<0.01). However, the serotonin levels and monoamine metabolizing enzyme activities in both EtOH + ginger extract and EtOH withdrawal + ginger extract group of rats was much lower as compared to the control group (p<0.05). The differences between EtOH intoxicated model and EW experimental group in comparison with their respective ginger extract treated groups, were highly significant(p<0.01).
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dyspepsia/Indigestion
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dyspepsia/Indigestion Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 3 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 2 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 5 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DICENTRINE 2 (-)-EPICATECHIN 2 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 2 Chemical Activity Count (-)-HYDROXYJASMONIC-ACID 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 3 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1'-ACETOXY-EUGENOL-ACETATE 1 1'-ACETOXYCHAVICOL-ACETATE 1 1,2,11,13,2,3'-HEXAHYDROVERNODALIN 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 7 1-METHYL-2-[(Z)-7-TRIDECENYL]-4-(1H)-QUINOLONE 1 1-METHYL-2-[(Z)-8-TRIDECENYL]-4-(1H)-QUINOLONE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11(S),13-DIHYDRO-8-DEOXYLACTUCIN 1 11(S),13-DIHYDROLACTUCIN
    [Show full text]
  • Pelargonium and Acute Bronchitis in Children
    HerbalGram 95 • August-October 2012 English Translation of 17th Century Herbal Classic • DMAA Update • 100+ Year-Old TCM Company Curcumin and Rheumatoid Arthritis • Cannabidiol in Medicinal Cannabis • The University Medicinal Plant Garden The Journal of the American Botanical Council Number 95 | August - October 2012 100+ Year-Old TCM Company Company TCM • Year-Old and Curcumin 100+ Rheumatoid Arthritis • DMAA Update • of 17 Translation English Pelargonium and Acute th Century Herbal Classic Bronchitis in Children US/CAN $6.95 www.herbalgram.org www.herbalgram.org Herb Profile Cinnamon Cinnamomum verum Family: Lauraceae INTRODUCTION defines commercial grades of 3 types of cassia bark, Chinese Cinnamomum verum is a small-to-moderate, bushy, evergreen type cassia (C. aromaticum), Indonesian type cassia (C. burma- nii), and Vietnamese type cassia (C. loureirii), with a separate tree that grows to about 52 feet (16 m) in height with smooth, 6 pinkish bark.1-3 Fresh leaf growth, called a flush, begins in the ISO standard for cinnamon bark (C. verum). The American monsoon season (June through September) and varies from green Spice Trade Association allows both cassia and cinnamon bark 2 to be labeled and sold as cinnamon for seasoning and spice to deep purple. The fragrant flowers are small, pale yellowish- 7 M I S S I O N D R I V E N : green, and are attractive to insects, particularly bees. Cinnamo- purposes in food products. However, if cinnamon is used as mum verum is native to Sri Lanka and southern India, from sea a dietary supplement ingredient, US Food and Drug Adminis- level to 2,953 feet (900 m) and is cultivated in Sri Lanka, the tration (FDA) labeling regulations require use of the common coastal regions of India (in the Western Ghats and adjoining name consistent with the name standardized in the American Herbal Products Association’s Herbs of Commerce, 2nd ed., which hills), parts of Africa (Madagascar and the Seychelles), Indone- 8 sia (Java), South America (Brazil), and the West Indies.1,3 This does differentiate between cassia and cinnamon.
    [Show full text]